BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SAPA-GP - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://sapagp.org
X-WR-CALDESC:Events for SAPA-GP
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210715T200000
DTEND;TZID=America/New_York:20210715T213000
DTSTAMP:20260425T123239
CREATED:20210702T001923Z
LAST-MODIFIED:20221201T192628Z
UID:3502-1626379200-1626384600@sapagp.org
SUMMARY:Cell & Gene Therapy (CGT) Rapid Growth in China: What Could be Your Share of the Pie?
DESCRIPTION:Register HereSpeakers:Amit AgarwalManaging Director\, Life Sciences San Francisco\, CA Amit is a Managing Director in Deloitte Consulting’s Life Sciences practice. Amit has more than 25 years of management consulting experience and has led multiple projects in both strategy and operations Amit co-leads the Next Generation Therapies practice. The practice focuses on advising clients on taking advantage of and/or developing strategic responses to new disruptive technologies in cell and gene therapies space. Amit has worked with Life Science clients in the U.S. Europe and Asia on high-impact projects.\nAmit also has experience as Vice President at Leerink Swann & Co.\, a boutique investment bank focused on the life sciences. He helped innovative life science companies raise capital\, identify merger and acquisition targets and negotiate strategic partnerships and alliances. He helped his clients generate nearly $1 billion of market value through the deals he helped broker.\nAmit publishes extensively in the business press and in peer reviewed academic journals on personalized medicine. Amit has presented at multiple conferences in North America\, South America and Europe and worked with industry associations on value-based care and risk sharing contracts in light of new technology paradigms.\nAmit holds an MBA in finance and technological innovation from the MIT Sloan School of Management and a bachelor’s degree in history and premed from Occidental College. Prior to business school\, Amit conducted research in neurobiology at the California Institute ofTechnology and was an American diplomat posted in China and the Middle East. Annie XuSpecialist Leader\, Life Sciences and Health Care\, Deloitte Consulting\, USAI am a core member of Deloitte’s NextGen Practice\, with a focus on helping cell and gene companies set up their supply chain and commercial platform to launch their products globally. I co-lead Deloitte’s Industry Working Group (IWG)\, working closely with industry leaders to design patient-centric solutions that provide CGT access to a broader patient population.\nRelevant experiences:\n1. Developed a digital strategy to support the first gene-editing product launch in the US and EMEA\n2. Performed the market landscape assessment for cell and gene therapies and developed the investment strategy for a PE firm\n3. Led patient journey development and market sizing for an ultra-rare disease gene therapy\, and develop launch strategy in Saudi\, Russia\, Japan\, and Brazil\nSupported commercial site certification across 80+ hospitals within the US for a CAR-T product\n4. Drove the global launch readiness for the most expensive gene therapy product outside of the US\, with a projected $1B sales revenue in 2020David Xie\, PhDPartner\, NextGen expertI’m a Partner based in Shanghai\, China with a focus on biotech and next generation therapies practice. We often take a China specific view and help clients to understand the intricate and fast-evolving policies environment and what it means for entry strategy\, regulatory path\, market access\, and go-to-market models. We also tackle next-generation specific issues such as site certification and supply chain visibility. My experience in CGT:\n1. Led multiple projects with leading overseas biopharma companies to help define China product regulatory paths\, market access and GTMs including CAR-T\, targeted oncology drugs\, and rare disease drugs\n2. Worked on global supply chain and China commercial excellence to define China entry and supply chain models for Cell & Gene Therapies\n3. Worked on the launch of multiple CAR-T products access and pricing strategy in China\n4. Worked on the companion genetic diagnosis tests clinical development and GTM assessment as part of the CGT product portfolio\n5. Represent the Deloitte Next Generation Therapies practice in China with thought leadership on driving In China For China business modelsJohn Law Strategy and Business Design Manager\, Deloitte Consulting\, ChinaJohn is a Shanghai based Manager at the Strategy & Business Design service\nline\, also known as Monitor Deloitte and now part of Strategy\, Analytics and M&A offering portfolio\, of Deloitte Consulting. He studied Biomedical Sciences at University of Oxford where he specialized in scientific data analysis as well as experimental testing; through which he developed a research oriented and data driven approach to solving problems.\nJohn possesses a diverse skill set from strategy to operations in Life Sciences\nand Health Care consulting. His strong written and verbal communication skills also contributed to his successful track record in interacting with clients across levels. John is fluent in English\, Mandarin Chinese and Cantonese Chinese.\nSelected project experience:\n• Assessed China competitive landscape as well as pricing and reimbursement environment for a leading British multinational pharmaco’s hepatocellular carcinoma CAR T; designed likely market access journey for client’s CAR T by formulating various reimbursement scenarios and price volume relationship\n• Evaluated China go to market model options for a leading Japanese multinational pharmco’s portfolio of gene therapies having identified relevant regulatory barriers; designed entry roadmap from entity set up\, clinical trials\, product and materials import to commercialization\n• Estimated China market size and attractiveness for a leading Japanese multinational medical device company’s cell processing center; identified use cases and customer segments and developed unique value propositions\nJohn holds a Master and a Bachelor degree in Biomedical Sciences from University of Oxford.
URL:https://sapagp.org/event/cell-gene-therapy-cgt-rapid-growth-in-china-what-could-be-your-share-of-the-pie/
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/07/July-15-Webinar-e1625185124573.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210616T200000
DTEND;TZID=America/New_York:20210616T210000
DTSTAMP:20260425T123239
CREATED:20210523T001848Z
LAST-MODIFIED:20221201T192640Z
UID:3469-1623873600-1623877200@sapagp.org
SUMMARY:Project Management and Beyond -- What you need to know
DESCRIPTION:Register Here
URL:https://sapagp.org/event/project-management-and-beyond-what-you-need-to-know/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/05/Screen-Shot-2021-05-22-at-17.29.34-PM-e1621729108251.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210531T200000
DTEND;TZID=America/New_York:20210531T200000
DTSTAMP:20260425T123239
CREATED:20210518T131519Z
LAST-MODIFIED:20221201T192650Z
UID:3464-1622491200-1622491200@sapagp.org
SUMMARY:Improve Your Presentations with Stress and Intonation
DESCRIPTION:Register Here
URL:https://sapagp.org/event/improve-your-presentations-with-stress-and-intonation/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/05/20210531-SAPAGP-Flyer-e1621343697926.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210428T200000
DTEND;TZID=America/New_York:20210428T210000
DTSTAMP:20260425T123239
CREATED:20210410T113545Z
LAST-MODIFIED:20221201T192700Z
UID:3446-1619640000-1619643600@sapagp.org
SUMMARY:Demystifying Life Sciences Business Development in the COVID Era
DESCRIPTION:Register Here  \nTopics including\, but not limited to: \n\nprocess around BD inside your organization\nyour role specifically\nBD best practices\nPost-COVID BD\nCareer advice for scientists interested in BD\n\n  \nSpeaker Info: \n\nJean-Sebastien (JS) Cleiftie\, CBO of Erytech Pharma (former Assoc. VP of Sanofi) (Linkedin)\nYelena Wetherill\, Director\, Alliance Management\, Business Development & Licensing at Novartis Institutes for BioMedical Research (NIBR) (Linkedin)\nDan Zheng\, Director for Global Transactions at Sanofi Partnering (Linkedin)\nAmy Jia Wang\, Director\, External R&D (Search & Evaluation) at Horizon (Linkedin)\nSally (Yuanheng) Wang Liang JD MPH\, VP of Business Development @ PepLib (Linkedin)\n\n(Sally will be the moderator and speaker) \n 
URL:https://sapagp.org/event/demystifying-life-sciences-business-development-in-the-covid-era/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/04/Screen-Shot-2021-04-09-at-23.54.31-PM-1-e1618054497276.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210331T200000
DTEND;TZID=America/New_York:20210331T210000
DTSTAMP:20260425T123239
CREATED:20210311T191209Z
LAST-MODIFIED:20221201T192711Z
UID:3428-1617220800-1617224400@sapagp.org
SUMMARY:High Impact Communication Skills
DESCRIPTION:How do you make your talks memorable?\nCan technical talks be made readily understandable?\nWhat are techniques for giving presentations with strong impact?\n\nIf you want answers to these questions and have a chance to network with colleagues\, attend SAPA GP’s career webinar.  We will use Zoom meetings to allow for more opportunities for networking.\n\nSpeakers:\nDavid Cragin\, PhD\, DABT\, Director Global Product Quality Complaint Operations\, Merck & Co\n\nSara Gao\,\n– Program director\, Wharton Executive education\n– Instructor of global village for future leaders of business and industry program\, Lehigh University\n\n\nBrought to you by\nSinoAmerican Pharmaceutical Association Greater Philadelphia\nCareer and Mentoring Group\nRegister HereView Recordings\nSorry\, your browser doesn't support embedded videos.
URL:https://sapagp.org/event/high-impact-communication-skills/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/03/Screen-Shot-2021-03-15-at-21.17.03-PM.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201210T200000
DTEND;TZID=America/New_York:20201210T210000
DTSTAMP:20260425T123239
CREATED:20201202T032256Z
LAST-MODIFIED:20221201T192734Z
UID:3384-1607630400-1607634000@sapagp.org
SUMMARY:Paving the Path to Commercialize Cell & Gene Therapies: Why a New Operating Model is Greatly Needed?
DESCRIPTION:Agenda \n\nRecent CGT market dynamics overview and the outlook\nBest practices for managing the special CGT supply chain and product delivery\nNew reimbursement models on a global basis\n\n\nSpeaker：Amit Agarwal\, Managing Director\, Deloitte Consulting \n\n\nAmit Agarwal \nManaging Director \nLife Sciences \nSan Francisco\, CA  \nAmit is a Managing Director in Deloitte Consulting’s Life Sciences practice. Amit has more than 25 years of management consulting experience and has led multiple projects in both strategy and operations  Amit co-leads the Next Generation Therapies practice.  The practice focuses on advising clients on taking advantage of and/or developing strategic responses to new disruptive technologies in cell and gene therapies space.  Amit has worked with Life Science clients in the U.S. Europe and Asia on high-impact projects. \nAmit also has experience as Vice President at Leerink Swann & Co.\, a boutique investment bank focused on the life sciences.  He helped innovative life science companies raise capital\, identify merger and acquisition targets and negotiate strategic partnerships and alliances. He helped his clients generate nearly $1 billion of market value through the deals he helped broker. \nAmit publishes extensively in the business press and in peer reviewed academic journals on personalized medicine.  Amit has presented at multiple conferences in North America\, South America and Europe and worked with industry associations on value-based care and risk sharing contracts in light of new technology paradigms. \nAmit holds an MBA in finance and technological innovation from the MIT Sloan School of Management and a bachelor’s degree in history and pre-med from Occidental College. Prior to business school\, Amit conducted research in neurobiology at the California Institute of Technology and was an American diplomat posted in China and the Middle East. \nThis webinar is sponsored by Deloitte. The Deloitte Chinese Services Group (CSG) provides professional support for life sciences and healthcare companies engaged in cross-border investments and business between Greater China region and the United States. https://bit.ly/2IX5MDf \nRegister Here
URL:https://sapagp.org/event/paving-the-path-to-commercialize-cell-gene-therapies-why-a-new-operating-model-is-greatly-needed/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2020/12/IMG_6108.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201111T200000
DTEND;TZID=America/New_York:20201111T210000
DTSTAMP:20260425T123239
CREATED:20201013T001500Z
LAST-MODIFIED:20221201T192751Z
UID:3305-1605124800-1605128400@sapagp.org
SUMMARY:Negotiation\, Influence\, and Conflict Resolution in the Office
DESCRIPTION:Speaker:\n1. Dianne Hart\, SHRM-SCP\, DDI\, Global Vice President/Chief Human Resources Officer\, IPS-Integrated Services \n2. David Cragin\, PhD\, DABT\, Director Global Complaint Management and External Affairs\, Merck & Co. \n3. Yangzhou Li\, PharmD\, Medical Writer\, Legend Biotech USA\, Inc. \nRegister Here
URL:https://sapagp.org/event/negotiation-influence-and-conflict-resolution-in-the-office/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/10/Nov-11-flyer-SAPA-GP.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201105T200000
DTEND;TZID=America/New_York:20201105T213000
DTSTAMP:20260425T123239
CREATED:20201013T000926Z
LAST-MODIFIED:20221201T192809Z
UID:3300-1604606400-1604611800@sapagp.org
SUMMARY:Latest perspectives and trends in global clinical development
DESCRIPTION:Topics and Speakers:\nIncluding China into Your Drug Development Strategy: Why\, When and How?\nJiansong Yang\, PhD\, CSO\, Tigermed\n\nDr. Jiansong Yang is the Chief Scientific Officer of Tigermed\, which is the largest clinical CRO in China. He’s also the Founder and CEO of Mosim (acquired by Tigermed company)\, which focuses on drug development strategy\, clinical study design\, and PK/PD data analysis. \nDr. Yang has over 15 years of experience in the pharmaceutical industry\, specializing in early drug development and clinical study design. Prior to Mosim\, he was Director of Clinical Pharmacology at GSK. He received his Ph.D. in Clinical Pharmacokinetics from the University of Sheffield\, UK. \nThe Future of Global Drug Development Beyond the Pandemic\nAmir Kalali\, MD\, Chairman\, CNS Summit\nDr. Amir Kalali is a physician scientist\, recognized globally as a leading innovator at the intersection of life sciences and technology\, and a convener of collaborative high impact forums. He is the Chairman and Chief Curator of the CNS Summit\, a forum focused on the future of life sciences\, and was the Founding Chairman\, and sits on the Executive Committee of the International Society for CNS Drug Development (ISCDD)\, one of the first independent non-profits to bring together leaders in drug development to collaborate. He has been involved in initiatives by the Institute of Medicine\, as well as the NIH FAST and the NIH NCATS program. Previously\, he was the Global Head of the Neuroscience Center of Excellence at Quintiles\, now known as IQVIA. In this role\, he was responsible for numerous successful drug development programs. He is a Professor of Psychiatry at the University of California San Diego\, Editor of the journal Innovations in Clinical Neuroscience\, and the Lead Editor of the book Essential CNS Drug Development. Dr. Kalali sits on the board of directors of both private and publicly traded companies and advises companies in the life sciences and technology sectors\, universities\, and the investment groups. \nRegister HereSponsored by Tigermed \nWebsite: tigermedgrp.com \nContact: fang.zhao@tigermedgrp.com
URL:https://sapagp.org/event/latest-perspectives-and-trends-in-global-clinical-development/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/10/Nov-5-flyer-SAPA-GP.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201014T200000
DTEND;TZID=America/New_York:20201014T213000
DTSTAMP:20260425T123239
CREATED:20201009T005503Z
LAST-MODIFIED:20221201T192940Z
UID:3296-1602705600-1602711000@sapagp.org
SUMMARY:Health Economics Outcome Research:  Value Evidence Generation for Life Sciences
DESCRIPTION:Speakers：\n– Lixia Yao\, PhD\, Director Real-world Data Analytics and Innovation\, Merck & Co.\n– Chang Xu\, MS\, Manager Janssen Scientific Affairs\n– Jingyi Qi\, MPH\, Associate Decision Support Analyst\, Gateway Health\n– Yulan Zhang\, MS\, Associate\, HEOR KMK Consulting Inc.\n– Candice Zhi\, Tsinghua University School of Economics and Management\n\nHighlights:\nHealth Economic Outcome Research (HEOR)\, Real Word Evidence and Market Access are rapidly growing fields worldwide\n– Learn about how these techniques are being used to give patients access to medicines\n– Understand the US and China’s approaches to these fields\nRegister Here
URL:https://sapagp.org/event/health-economics-outcome-research-value-evidence-generation-for-life-sciences/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2020/10/unnamed-1.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T200000
DTEND;TZID=America/New_York:20200924T210000
DTSTAMP:20260425T123239
CREATED:20200917T001443Z
LAST-MODIFIED:20221201T193000Z
UID:2820-1600977600-1600981200@sapagp.org
SUMMARY:The Chinese American Experience: Evolving Tensions in US-China Relations
DESCRIPTION:Title: The Chinese American Experience: Evolving Tensions in US-China Relations \nTime: Thursday\, September 24\, 8:00-9:00 PM\, EDT \nSpeaker: \n\nBrian A. Sun Of Counsel\, Jones Day; Investigations & White Collar Defense\, Business & Tort Litigation\nChristopher K. Pelham Of Counsel\, Jones Day; Global Disputes\, Investigations & White Collar Defense\, Technology\n\nHighlights : \n\n US  government national security concerns\n IP/trade secrets theft\n Organizing and responding to the “loyalty” challenges raised by the current environment and the return of the Fifties type scrutiny and persecution of Asian Pacific Americans\n\nRegister Here Speaker’s BioBrian Sun has earned a national reputation as a distinguished trial lawyer in complex business litigation and white collar criminal defense. He is a former federal prosecutor\, a Fellow of the American College of Trial Lawyers\, and has been named by Lawdragon Magazine as one of America’s 500 leading lawyers. Brian is recognized as a Band 1 lawyer by Chambers in the area of white collar criminal defense and government investigations. He was also Partner-in-Charge of the Los Angeles Office for several years. Brian’s litigation practice covers a wide range of areas\, including matters involving intellectual property disputes\, Foreign Corrupt Practices Act (FCPA)\, public corruption\, entertainment\, contractual disputes\, and fraud. Brian has a substantial cross-border practice\, and his clients include Global Fortune 300 institutions and individuals embroiled in high-stakes litigation. Over the years he has represented such clients as Hon Hai Precision Co. (Foxconn)\, Mattel\, Emerson Electric Co.\, the City of Los Angeles\, and a number of individuals\, including former Orange County Sheriff Michael Carona and Dr. Wen Ho Lee in his successful civil lawsuit against the United States government. Brian is a former president of the National Asian Pacific American Bar Association (NAPABA) and the Los Angeles Regional Foodbank. He has been honored by NAPABA with its Trailblazer Award and by the Southern California Chinese Lawyers Association with its Lifetime Achievement Award. He also served as a deputy general counsel to the Christopher Commission\, which recommended sweeping reforms of the Los Angeles Police Department in the wake of the Rodney King incident. \nChris Pelham is a former Assistant United States Attorney who serves international clients with dispute\, regulatory\, litigation\, and internal investigation needs in China and East Asia. Chris is one of only a small number of American former prosecutors who are based in mainland China. From his location in Shanghai\, Chris provides Chinese and East Asian clients with immediate insight into\, and advice about\, the U.S. litigation and criminal systems. He also provides U.S. and European clients with insight into current business and legal issues in China. Chris represents multinational companies involved in commercial disputes in Asia. His engagements have included disputes over breaches of contract\, copyright infringement\, trade secrets theft\, and fraud\, both in U.S. federal and state courts and in arbitration. He also represents Chinese and Asian clients with pending investigations before U.S. prosecutors. Chris’s work has included highly sensitive matters such as money laundering and health care fraud. Chris also assists U.S. and European companies with compliance and anticorruption issues in China and East Asia. He helps clients investigate allegations of embezzlement\, conflicts of interest\, and commercial and public bribery involving their employees\, contractors\, and joint venture partners. Chris previously served eight years with the United States Department of Justice. He tried 10 felony cases before federal juries\, submitted at least 10 different appeals briefs\, and orally argued before the United States Court of Appeals on four cases. Chris has been active with several Los Angeles-based nonprofits\, including School on Wheels and the L.A. Center for Law & Justice\, as well as with Stepping Stones in Shanghai
URL:https://sapagp.org/event/the-chinese-american-experience-evolving-tensions-in-us-china-relations/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/09/9-24-2020-webinar-flyer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200910T200000
DTEND;TZID=America/New_York:20200910T210000
DTSTAMP:20260425T123239
CREATED:20200730T124257Z
LAST-MODIFIED:20221201T193021Z
UID:2780-1599768000-1599771600@sapagp.org
SUMMARY:Control Your Own Destiny
DESCRIPTION:Register hereAbout this Event\n\n\nZoom meeting information will be sent to your email address after registration. \nSpeaker:\nCynthia Cai\, M Eng\, MBA\, PhD \nPresident\,Tharton Consulting & Senior Advisor for Northern Light Capital
URL:https://sapagp.org/event/control-your-own-destiny/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/07/Screen-Shot-2020-08-02-at-11.00.50-1-e1596466196687.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200820T200000
DTEND;TZID=America/New_York:20200820T220000
DTSTAMP:20260425T123239
CREATED:20200730T120727Z
LAST-MODIFIED:20221201T193037Z
UID:2778-1597953600-1597960800@sapagp.org
SUMMARY:Arm yourself with legal and regulatory knowledge to navigate successfully in the new US-China business environment
DESCRIPTION:Register here\n\n\n\nArm yourself with legal and regulatory knowledge to navigate successfully in the new US-China business environment\n\n\n\n\n\n\nAbout this Event\n\n\nZoom meeting information will be sent to your email address after registration. \nSpeakers:\nJoshua Gruenspecht\, Partner at WSGR \nJennifer Fang\, Partner at WSGR \nZhipping (Louis) Liu\, Partner at Liu\, Chen Hoffman\, LLP \nYong Chen\, Partner at Liu\, Chen\, Hoffman\, LLP \n\nTopics by each speaker:\n1. Joshua Gruenspecht: \n· New CFIUS rules and implications for Chinese investments in the US in the life sciences industry\, as well as licensing into China\, and JV in China; \n· How CFIUS rules are being implemented as US-China relations continue to deteriorate\, and how to mitigate risks \n2. Jennifer Fang: \n· Trends in life sciences investments\, with a particular focus on milestone/tranched closings\, their pitfalls and considerations\, including pay to play\, voting issues\, and closing conditions. \n3. Louis Liu: \n· How to work with professional advisors while doing M&A or PE or JV deals with US counterparts; \n· How to conduct legal due diligence investigations of US counterparts; \n· How to integrate legal due diligence results\, commercial terms and legal terms into transaction documents with US counterparts; \n· The most common legal mistakes made by Chinese businesses doing deals or opening operations in the US. \n4. Yong Chen: \n· Fundamentals of Intellectual Property for Researchers and Entrepreneurs \n· Mitigation of Risks of Intellectual Property Violations in the New Era of Sino-US Relationship \nSpeaker Bio:\nJoshua Gruenspecht:Joshua Gruenspecht is a partner in the Washington\, D.C.\, office of Wilson Sonsini Goodrich & Rosati\, where he advises domestic and foreign investors\, funds\, established companies and startups in regulatory\, investigative\, and enforcement matters. He routinely represents parties before the Committee on Foreign Investment in the United States (CFIUS) and other government bodies on national security\, cybersecurity and communications matters. Gruenspecht has advised clients on CFIUS risk in hundreds of matters and is regularly invited to speak on CFIUS issues. \nJoshua has been recognized as an International Trade: CFIUS Expert by Chambers USA\, as one of the top 40 attorneys under the age of 40 in Washington\, DC by DCA Live\, and as a leading attorney in The Legal 500 U.S. in the areas of Telecom and Broadcast: Regulatory and Transactional. Joshua regularly helps U.S. companies and foreign investors in understanding and allocating CFIUS risk\, determining whether filings are required or advisable\, and navigating the CFIUS process. In addition\, he represents domestic businesses and foreign entities before the Defense Counterintelligence and Security Agency (DCSA)\, the Federal Communications Commission (FCC)\, federal defense and intelligence agencies\, state utilities commissions\, and other government bodies. \nPrior to joining Wilson Sonsini\, Joshua worked at a multinational law firm based in Washington\, D.C. He was previously a Cybersecurity Fellow with the Center for Democracy and Technology\, as well as an engineer working on network security research and development for the federal government and BBN Technologies\, focusing on device exploitation and computer network exploitation. Joshua has been quoted in prominent publications including The New York Times\, The Atlantic Monthly\, the Voice of America News\, and Law360. He holds a J.D. from Harvard Law School and a B.S. in Computer Science and English Literature from Yale University. \nJennifer Fang \nJennifer Fang is a corporate and securities partner in the Boston office of Wilson Sonsini Goodrich & Rosati. She helps innovative start-ups grow into successful enterprises by providing counsel to the founders\, management teams\, and boards and by handling the legal and strategic business issues and transactions that arise at each stage. She is experienced in negotiating and executing a variety of corporate transactions\, including conversions\, spinouts\, debt and equity financings\, public offerings\, PIPEs\, mergers and acquisitions\, and joint ventures. She also counsels venture capital\, growth capital\, and strategic investors with respect to their investment transactions and their existing portfolio companies. Her practice focuses on companies that can improve patient lives and healthcare through innovations and advances\, including in gene editing\, cell therapy\, novel therapeutics\, synthetic biology\, proteomics\, diagnostics\, bioinformatics\, medical devices\, and research and manufacturing tools and processes. \nShe is a frequent speaker on corporate and securities topics\, such as company formation risks\, equity compensation issues\, angel and venture financing terms\, and founder pitfalls\, and currently serves on the General Counsel Advisory Board of the National Venture Capital Association. In her free time\, she enjoys mentoring young lawyers\, entrepreneurs\, and investors in the local community. Ms. Fang received her J.D. from the University of Pennsylvania and a Master of Engineering in Biological Engineering and a Bachelor of Science in Biology from the Massachusetts Institute of Technology. \nZhiping Liu \nMr. Liu specializes in corporate law\, including corporate governance\, mergers and acquisitions\, commercial loans\, joint ventures and related areas. Mr. Liu has practiced in leading Wall Street and Silicon Valley law firms for more than seven years\, when he completed more than 100 large-scale transactions\, including mergers\, acquisitions\, investments\, and restructurings\, secured lending totaling more than $7 billion. Mr. Liu now leads the business practices of Liu\, Chen & Hoffman LLP\, a Chinese-American owned boutique business law firm that focuses on cross-border transactions\, intellectual property law and commercial dispute resolutions. Mr. Liu received his Juris Doctorate from New York University School of Law and is admitted to practice in New York and Georgia. \nYong Chen \nYong Chen is a founding partner of Liu\, Chen & Hoffman LLP. His practices focus on intellectual property law. Dr. Chen has counseled a range of clients including petrochemical\, chemical engineering\, pharmaceutical\, medical devices companies\, universities and research institutions in their patent and trademark portfolio management\, application drafting and prosecution\, invalidity/infringement investigation\, freedom-to-operate studies\, due diligence\, technology transfer and licensing\, and litigation. Dr. Chen earned his J.D. from New York University and his Ph.D. in Chemistry and M.S. in Computer Science from the Graduate Center of the City University of New York. He is admitted to practice in New York and before the US Patent and Trademark Office.
URL:https://sapagp.org/event/arm-with-legal-knowledge-to-navigate-in-new-us-china-business-environment/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/07/Screen-Shot-2020-08-01-at-10.00.54-e1596474290840.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200805T200000
DTEND;TZID=America/New_York:20200805T210000
DTSTAMP:20260425T123239
CREATED:20200614T210512Z
LAST-MODIFIED:20221201T193051Z
UID:2631-1596657600-1596661200@sapagp.org
SUMMARY:Career workshop: Accent reduction
DESCRIPTION:Career Workshop: Accent Reduction for Chinese Speakers: How to Speak with Clarity\, Cadence and Confidence \nSpeaker: Lauren Supraner\, President\, CAL Learning\, Accent Reduction and Intercultural Communication Expert; Author: Accent Reduction for Chinese Speakers; Leadership communication coach; Intercultural communication professional \nRegister HereSponsor
URL:https://sapagp.org/event/career-workshop-accent-reduction/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/06/Lauren-Supraner-e1592168688704.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200723T203000
DTEND;TZID=America/New_York:20200723T220000
DTSTAMP:20260425T123239
CREATED:20200621T003703Z
LAST-MODIFIED:20221201T193104Z
UID:2712-1595536200-1595541600@sapagp.org
SUMMARY:Buckle up for a bumpy ride – capital market update and exit strategy planning under the global pandemic
DESCRIPTION:Speakers \n\nRebecca Chan\, Partner\, Audit & Assurance\, Deloitte China\nLawrence Jin\, Partner\, Audit & Assurance\, Deloitte China\nDanny Wang\, Managing Director\, Audit & Assurance\, Deloitte & Touche LLP\nLili Zheng\, Partner\, International Tax\, Deloitte Tax LLP\n\n  \nAgenda  \n\nLegislative updates\nCapital market updates and exit strategy planning\n\n\nHK\, Mainland China\, US IPO trends & market comparison\nPanel Discussion – what you have seen from the market\n\n\nHow to recover and thrive in the current market situation\n\n\nCorporate structures and IP planning\nGlobal incentives for R&D\n\nRegister HereSpeakers:\nRebecca Chan \nNational Capital Market Leader\, China; Partner\, Audit & Assurance; Deloitte Touche Tohmatsu \nOffice: Hong Kong\, China \nRebecca has over 32 years of experience working with international accounting firms as well as the Hong Kong Exchanges and Clearing Limited where she headed the IPO Transactions Department and the Accounting Affairs Department of their Listing Division. She has been heavily involved in providing accounting and listing rules advice to clients and working on IPOs and post-listing transactions. Rebecca also provided regulatory rules suggestions to various overseas stock exchanges or markets. \nShe had also acted as a member of the Financial Reporting Advisory Panel of HKEx for the maximum term of six years. Rebecca is also a past member of the Dual Filing Advisory Group of the Securities & Futures Commission of Hong Kong responsible for advising on treatment of cases and policy issues under the dual filing regime for listing in Hong Kong. She is the only accountant by professional training in town who had acted as the Head of IPO Transactions Department in HKEx. \nLawrence Jin \nLife Sciences & Health Care (LSHC) National Audit leader\, China Eastern Region Market Leader; Partner\, Audit & Assurance; Deloitte China \nOffice: Shanghai\, China \nLawrence has over 24 years of auditing and advisory experience in both China and UK. He founded and currently leads LSHC audit practice in Deloitte China and has successfully led a number of high-profile IPOs in the sector in both China\, HK and the US capital markets. \nDanny Wang \nAudit Leader\, Deloitte US Chinese Services Group; Managing Director\, Audit & Assurance; Deloitte & Touche LLP \nOffice: New York\, USA \nDanny has over 18 years of experience in the financial services industry\, where he has led a number of audits of SEC registrants\, broker and dealers in securities and investment advisors. Danny’s focus is primarily on global audit coordination and execution\, SEC reporting and a variety of technical accounting topics. \nLili Zheng \nDeputy Managing Partner of US Chinese Services Group\, Asia Pacific Cross-Border Services Leader; Partner\, International Tax; Deloitte Tax LLP \nOffice: New York\, USA \nLili has more than 30 years of cross-border tax planning experience. She is responsible for Deloitte’s overall cross-functional services to MNCs investing Asia as well as Chinese & Asian clients investing in the US. Lili provides practical solutions to clients on their cross-border investment structuring\, IP planning\, JV planning\, M&A\, entry and exit strategies. \nSponsored by
URL:https://sapagp.org/event/buckle-up-for-a-bumpy-ride-capital-market-update-and-exit-strategy-planning-under-the-global-pandemic/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/06/July-23-webinar-revised-final-07152020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200709T200000
DTEND;TZID=America/New_York:20200709T210000
DTSTAMP:20260425T123239
CREATED:20200614T210104Z
LAST-MODIFIED:20221201T193118Z
UID:2627-1594324800-1594328400@sapagp.org
SUMMARY:Secret to success: building one meaningful relationship at a time
DESCRIPTION:Career workshop: Secret to success: building one meaningful relationship at a time \nSpeaker: Sara Gao\, program director\, Wharton executive education; instructor of global village for future leaders of business and industry program\, Lehigh University \nNo one can succeed alone. Ask anyone who achieved anything in life\, they will tell you somewhere along the way\, they were mentored\, encouraged\, inspired or lifted towards their success. From finding a potential customer to landing a dream job\, from partnering with a new colleague to leading an effective team\, relationship building is the secret to success. It is also a critical skill that we do not necessarily learn in school. In this interactive session\, we are going to explore some of the best practices in building meaningful relationships\, especially how we can pivot in our new reality. Come prepared with your audio and video on\, you will have an opportunity to practice live in virtual breakout rooms. \nSpeaker: Born in China\, educated in Europe\, Sara Gao has worked in Europe\, Asia\, and the USA as a talent development expert over the past 16 years. Sara currently works as program director at Wharton Executive Education. Her passion is to bring senior leaders from various industries around the world to a life changing learning experience\, so they are ready to create positive impacts for a better world. As a career coach\, Sara specializes on coaching Asian professionals to become successful leaders in a multicultural environment. \nRegister HereSponsored by\nView Recordings\nPart 1 \nSorry\, your browser doesn't support embedded videos.Part 2 \nSorry\, your browser doesn't support embedded videos.
URL:https://sapagp.org/event/secret-to-success-building-one-meaningful-relationship-at-a-time/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/06/Sara-Gao-e1592168390975.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200625T210000
DTEND;TZID=America/New_York:20200625T220000
DTSTAMP:20260425T123239
CREATED:20200614T203506Z
LAST-MODIFIED:20221201T193133Z
UID:2619-1593118800-1593122400@sapagp.org
SUMMARY:Creative Vaccine Development Strategies Amid the COVID-19 Outbreak
DESCRIPTION:Register HereCOVID-19 has wrought shutdowns and thousands of global deaths for almost six months. People are anxiously waiting for the chance to return to normal routines. Vaccines may bring that hope. Many companies have joined the race and began the development of COVID-19 vaccines. Some frontrunners have entered clinical trials. What are the differences between these vaccines? How to develop a vaccine in such a short time\, and what can we learn from this COVID-19 pandemic? Join us in this webinar. Dr. Li will answer these questions and share experiences on vaccine development strategies! \nSpeaker: Dr. Hangwen Li is the founder\, President and CEO of Stemirna Therapeutics. Dr. Li has over 20 years of experience in cancer research and treatment. His areas of interest include immunotherapy\, RNA therapeutics and cancer stem cells. Dr. Li’s published articles have been cited more than 2\,000 times. Dr. Li received his Ph.D. degree from the University of Texas M.D. Anderson Cancer Center.
URL:https://sapagp.org/event/creative-vaccine-development-strategies-amid-the-covid-19-outbreak/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/06/Screen-Shot-2020-06-13-at-22.16.47-1-e1592167853589.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200514T200000
DTEND;TZID=America/New_York:20200514T213000
DTSTAMP:20260425T123239
CREATED:20200504T001831Z
LAST-MODIFIED:20221201T193147Z
UID:2523-1589486400-1589491800@sapagp.org
SUMMARY:Learn from an expert:  Interviewing tips YOU need to know!
DESCRIPTION:What do you need to know about phone\, video\, and in-person interviews? What do you need to do to prepare for interviews? Learn from an expert: Interviewing tips YOU need to know! \nRegister HereSpeaker: \nDennis M. Gross\, M.S.\, Ph.D. \nDr. Gross has extensive experience in industry and academia. He received his Ph.D. in Cell Biology from the University of California\, Los Angeles. He did his postdoctoral training at Tulane University School of Medicine before joining the Merck Research Labs where he worked for 29 years retiring as Senior Director. He also serves as a Professor or Adjunct Professor at three universities and is the CEO of the Pennsylvania Drug Discovery Institute. In his talk\, he will offer some of the key things to be aware of when preparing for interviews. \nView Recordings \nSorry\, your browser doesn't support embedded videos.
URL:https://sapagp.org/event/learn-from-an-expert-interviewing-tips-you-need-to-know/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2020/05/online-video-call-interview-vector.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200424T120000
DTEND;TZID=America/New_York:20200424T130000
DTSTAMP:20260425T123239
CREATED:20200422T230153Z
LAST-MODIFIED:20221201T193204Z
UID:2511-1587729600-1587733200@sapagp.org
SUMMARY:COVID-19 Tax Relief under the CARES Act
DESCRIPTION:Speakers:\n1. Lili Zheng\, Partner\, Deloitte Tax LLP \n2. Priscilla Zhang\, Managing Director\, Deloitte Tax LLP \n3. Lynn Yang\, Managing Director\, Deloitte Tax LLP \nRegister Here
URL:https://sapagp.org/event/covid-19-tax-relief-under-the-cares-act/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2020/04/unnamed-scaled-e1587581895120.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
END:VCALENDAR